Moderna said the submission is based on the FDA's recommendation that vaccine makers update their jabs to target omicron subvariant XBB.1.5.
from International: Top News And Analysis https://ift.tt/2HRlJT8
via IFTTT
Thursday, June 22, 2023
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment